Director, US Forecasting & Analytics– Vaccines & Immune Therapies

Director, US Forecasting & Analytics – Vaccines & Immune Therapies (V&I)

Wilmington, DE

Global Insights, Analytics & Forecasting, BBU

Hybrid Work- on average 3 days a week from office

The Director, US Forecasting & Analytics – Vaccines & Immune Therapies is a senior commercial insights leader responsible for US demand forecasting and analytics across the V&I portfolio. The role is predominantly forecast-focused, serving as the US forecasting lead and strategic thought partner to Marketing, Finance, Market Access, and US teams. The role also includes people leadership, vendor management, and forecasting-adjacent analytics leadership to ensure the effective deployment of analytical resources and continuous evolution of forecasting and insight capabilities within V&I.

Time allocation may vary by business cycle and portfolio priorities. This position plays a critical role in shaping commercial expectations, risk and opportunity framing, and executive decision-making for in-market and late-stage pipeline vaccines and immune therapies.

• Lead US short-term and long-term demand forecasts (TRx, NBRx, volume, patients, revenue) for V&I assets using robust, patient-based and market-based models
• Own forecast methodology, assumptions, and governance, ensuring objectivity, transparency, and consistency with enterprise standards
• Integrate primary market research, epidemiology, competitive intelligence, access dynamics, and real-world data into forecast models
• Proactively identify and quantify key risks and opportunities through scenario and sensitivity analyses
• Partner closely with Finance, Market Access & Pricing, Marketing, Sales, Medical, and Global Forecasting to ensure alignment on assumptions and implications
• Support business planning, governance reviews, and opportunity assessments with clear, executive-ready narratives
• Serve as a trusted advisor to senior marketing and finance leadership, clearly articulating forecast drivers and changes

• Provide leadership over forecasting-adjacent analytics, ensuring advanced analytics and insights are embedded into forecasting and business planning
• Manage and prioritize internal analysts, contractors, and external vendors supporting forecasting and analytics deliverables
• Partner with data analytics resources, Global IA&F, and GIBEX capability teams to deploy new tools, data sources, and modeling approaches
• Champion and identify new ways to embed AI and advanced automation into the practice of data analytics and forecasting to drive efficiency, scalability, and decision quality
• Champion continuous improvement in forecasting processes, AI-enabled modeling, and automation
• Contribute to the development and sharing of best practices across the V&I forecasting community

• Bachelor’s degree in a quantitative, scientific, or business-related field required (e.g., Statistics, Economics, Mathematics, Engineering, Computer/Data Science).
• 8+ years’ experience in US pharmaceutical commercial forecasting, including in-market and late-stage pipeline assets
• Hands-on model ownership experience (build, refresh, and performance tracking) across short- and long-term horizons
• Expertise in scenario-based forecasting, sensitivity analysis, and driver-based narratives to support senior decision-making
• Strong capability integrating multiple data types (e.g., IQVIA, claims, epidemiology, RWD/RWE, primary research) into coherent, decision-grade forecasts
• Working knowledge of advanced analytics/ML approaches (e.g., time series, causal inference, ensembles) and where they add value vs. traditional methods
• Fluency in modern analytics tooling and automation (e.g., Python/R/SQL, BI/visualization), with ability to partner effectively with data engineering and analytics teams
• Demonstrated forecast governance and model risk discipline (traceable assumptions, documentation, and clear explanations)
• Strong understanding of US market access and payer dynamics and how they impact demand (coverage, contracting, channel, policy)
• Exceptional communication: translates complex analysis into clear,…